Evaluating commercial multimodal AI for diabetic eye screening and implications for an alternative regulatory pathway

Overview of attention for article published in npj Digital Medicine, December 2025

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter: 4 X users

bluesky: 1 Bluesky user

Readers on

mendeley: 15 Mendeley

So far, Altmetric has seen 6 X posts from 4 X users, with an upper bound of 9,918 followers.

@heysamir_ @anamika__x We have had liability for our (FDA approved) autonomous AI for the diabetic eye exam since 2018. https://t.co/MQkAhNS08C https://t.co/HdvRWEBBwF

RT @TinglongDai: Link to the @npjDigitalMed study: https://t.co/RwOmOLslYs

Link to the @npjDigitalMed study: https://t.co/RwOmOLslYs

@WillManidis I mentioned that new paper on medical frontier llm regulation. It is finally online (pre-proof for now): https://t.co/HdvRWEBBwF

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 2 additional X posts.